athenahealth Inc. (ATHN) Stock Rating Upgraded by Evercore ISI
Evercore ISI upgraded shares of athenahealth Inc. (NASDAQ:ATHN) from a hold rating to a buy rating in a report published on Monday morning. Evercore ISI currently has $152.00 target price on the stock.
ATHN has been the topic of several other research reports. Canaccord Genuity reissued a hold rating and set a $142.00 target price on shares of athenahealth in a research report on Wednesday, June 29th. Stifel Nicolaus began coverage on athenahealth in a research report on Wednesday, August 31st. They set a hold rating on the stock. FBR & Co cut their target price on athenahealth from $145.00 to $140.00 and set a market perform rating on the stock in a research report on Friday, July 22nd. Deutsche Bank AG downgraded athenahealth from a buy rating to a hold rating and cut their target price for the company from $165.00 to $147.00 in a research report on Friday, July 22nd. Finally, Zacks Investment Research downgraded athenahealth from a strong-buy rating to a hold rating in a research report on Tuesday, July 12th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus price target of $149.70.
athenahealth (NASDAQ:ATHN) opened at 126.34 on Monday. athenahealth has a one year low of $114.59 and a one year high of $170.42. The company has a market capitalization of $4.97 billion, a P/E ratio of 464.49 and a beta of 1.28. The stock’s 50 day moving average price is $123.69 and its 200 day moving average price is $129.72.
athenahealth (NASDAQ:ATHN) last released its earnings results on Thursday, July 21st. The company reported $0.34 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by $0.08. The company had revenue of $261.90 million for the quarter, compared to the consensus estimate of $274.07 million. athenahealth had a net margin of 1.06% and a return on equity of 5.16%. Equities analysts anticipate that athenahealth will post $1.77 EPS for the current fiscal year.
In other athenahealth news, VP Karl Stubelis sold 928 shares of athenahealth stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $123.36, for a total value of $114,478.08. Following the transaction, the vice president now owns 1,375 shares in the company, valued at $169,620. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Brandon H. Hull sold 2,400 shares of athenahealth stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $130.00, for a total transaction of $312,000.00. Following the completion of the transaction, the director now owns 3,987 shares in the company, valued at approximately $518,310. The disclosure for this sale can be found here. Corporate insiders own 3.04% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Glenmede Trust Co. NA raised its position in athenahealth by 66.3% in the first quarter. Glenmede Trust Co. NA now owns 6,253 shares of the company’s stock valued at $867,000 after buying an additional 2,492 shares during the period. Aperio Group LLC raised its position in athenahealth by 11.6% in the first quarter. Aperio Group LLC now owns 3,429 shares of the company’s stock valued at $476,000 after buying an additional 357 shares during the period. Pacad Investment Ltd. acquired a new position in athenahealth during the first quarter valued at about $222,000. Franklin Resources Inc. raised its position in athenahealth by 10.8% in the first quarter. Franklin Resources Inc. now owns 544,811 shares of the company’s stock valued at $75,609,000 after buying an additional 53,300 shares during the period. Finally, BlackRock Inc. raised its position in athenahealth by 273.8% in the first quarter. BlackRock Inc. now owns 4,508 shares of the company’s stock valued at $625,000 after buying an additional 3,302 shares during the period.
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.